Economic evaluation of a randomized trial comparinghelicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting

Clinical Therapeutics - Tập 27 - Trang 1647-1657 - 2005
Rogier M. Klok1, Nicolaas L.A. Arents2, Robin de Vries1, Jacob C. Thijs3, Jacobus R.B.J. Brouwers1, Jan H. Kleibeuker4, Maarten J. Postma1
1Groningen University Institute for Drug Exploration, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen, the Netherlands
2Department of MedicalMicrobiology, University Medical Centre Groningen, Groningen, The Netherlands
3Department of Internal Medicine, Bethesda Hospital, Hoogeveen, The Netherlands
4Department of Gastroenterology,University Medical Centre Groningen, Groningen, The Netherlands

Tài liệu tham khảo

Shaib, 2004, The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States, Am J Gastroenterol, 99, 2210, 10.1111/j.1572-0241.2004.40052.x Moayyedi, 2002, Clinical and economic consequences of dyspepsia in the community, Gut, 50 Kahn, 1985, Endoscopy in the Evaluation of Dyspepsia. United States 1984. Health and Public Policy Committee, American College of Physicians, Philadelphia,Pennsylvania, Ann Intern Med, 102, 266 Talley, 1998, AGA Technical review: Evaluation of dyspepsia, Gastroenterolog, 114, 582, 10.1016/S0016-5085(98)70542-6 Talley, 1991, Drug treatment of functional dyspepsia, Scand J Gastroenterol Suppl, 182, 47 Veldhuyzen, 1996, Drug treatment of functional dyspepsia: A systematic analysis of trial methodology with recommendations for design of future trials, Am J Gastroenterol, 91, 660 Graham, 1992, Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: A double-blind, multicenter, 6-month study, Gastroenterolog, 102, 1289, 10.1016/0016-5085(92)90767-S Dammann, 1993, Efficacy of continuous therapy for peptic ulcer in controlled clinical trials, Aliment Pharmacol Ther, 7, 17 Hetzel, 1988, Healing and relapse of severe peptic esophagitis after treatment with omeprazole, Gastroenterology, 95, 903, 10.1016/0016-5085(88)90162-X Koelz, 1986, Healing and relapse of reflux esophagitis during treatment with ranitidine, Gastroenterology, 91, 1198, 10.1016/S0016-5085(86)80017-8 Klok, 2001, Pharmacoeconomics of Helicobacter pylori: Eradication versus maintenance therapy in controlling peptic ulcer disease, Exp Rev Pharmacoeconom Outcomes Res, 1, 19, 10.1586/14737167.1.1.19 Delaney, 2003, Initial management strategies for dyspepsia, Cochrane Database Syst Rev, 2, CD001961 Arents, 2003, Approach to treatment of dyspepsia in primary care: A randomised trial comparing “test-and-treat” with prompt endoscopy, Arch Intern Med., 163, 1606, 10.1001/archinte.163.13.1606 1999 1999 1999 Oostenbrink, 2002, Standardisation of costs: The Dutch Manual for Costing in economic evaluations, PharmacoEconomics, 20, 443, 10.2165/00019053-200220070-00002 Hays, 1993, The RAND 36-Item Health Survey 1.0, Health Econ, 2, 217, 10.1002/hec.4730020305 Nichol, 2001, Evaluating qualityadjusted life years: Estimation of the health utility index (HUI2) from the SF-36, Med Decis Making, 21, 105, 10.1177/02729890122062352 Torrance, 1996, Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index Mark 2, Med Care, 34, 702, 10.1097/00005650-199607000-00004 Furlong, 2001, The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies, Ann Med, 33, 375, 10.3109/07853890109002092 Cook, 2000, Use of angular transformation for ratio estimation in cost-effectiveness analysis, Stat Med, 19, 2989, 10.1002/1097-0258(20001115)19:21<2989::AID-SIM599>3.0.CO;2-G Efron, 1979, Bootstrap methods: Another look at the jackknife, Ann Statistics, 7, 1, 10.1214/aos/1176344552 van Hout, 1994, Costs, effects and C/E-ratios alongside a clinical trial, Health Econ, 3, 309, 10.1002/hec.4730030505 Bhattacharyya, 1977 Neter, 1974 Zwart-van Rijkom, 2000, Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMETProject, PharmacoEconomics, 18, 149, 10.2165/00019053-200018020-00005 Klok, 2004, Four quadrants of the cost-effectiveness plane: Some considerations on the south-west quadrant, Exp Rev Pharmacoeconom Outcomes Res, 4, 599, 10.1586/14737167.4.6.599 Fendrick, 1995, Alternative management strategies for patients with suspected peptic ulcer disease, Ann Intern Med, 123, 260, 10.7326/0003-4819-123-4-199508150-00003 Silverstein, 1996, Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis, Gastroenterologl, 110, 72, 10.1053/gast.1996.v110.pm8536890 Sonnenberg, 1996, Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects, Am J Gastroenterol, 91, 1773 Briggs, 1996, Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age, BMJ, 312, 1321, 10.1136/bmj.312.7042.1321 Ebell, 1997, Evaluation of the dyspeptic patient: A cost-utility study, J Fam Pract, 44, 545 Ofman, 1997, Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: Clinical and economic consequences, Ann Intern Med, 126, 280, 10.7326/0003-4819-126-4-199702150-00004 Laheij, 1997, Management in general practice of patients with persistent dyspepsia. A decision analysis, J Clin Gastroenterol, 25, 563, 10.1097/00004836-199712000-00002 Olson, 1998, Combined empiric treatment and specific Hp screening and treatment decrease the cost of evaluating epigastric abdominal pain, Gastroenterology, 114, A248, 10.1016/S0016-5085(98)81009-3 Laheij, 1998, Randomized controlled trial of omeprazole or en doscopy in patients with persistent dyspepsia: A cost-effectiveness analysis, Aliment Pharmacol Ther, 12, 1249, 10.1046/j.1365-2036.1998.00423.x Duggan, 2000, Randomised controlled trial of four dyspepsia management strategies in primary care with 12 months follow-up, Gastroenterology, 118, A438, 10.1016/S0016-5085(00)83864-0 Dowie, 2004, Why cost-effectiveness should trump (clinical) effectiveness: The ethical economics of the South West quadrant, Health Econ, 13, 453, 10.1002/hec.861 O'Brien, 2002, Is there a kink in consumers' threshold value for costeffectiveness in health care, Health Econ, 11, 175, 10.1002/hec.655 Lassen, 2000, Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: A randomised trial, Lancet, 356, 455, 10.1016/S0140-6736(00)02553-8 Bytzer, 1994, Empirical H2-blocker therapy or prompt endos copy in management of dyspepsia, Lancet, 343, 811, 10.1016/S0140-6736(94)92023-0 Delaney, 2001, Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care, BMJ, 322, 898, 10.1136/bmj.322.7291.898 Loffeld, 2001, The occurrence ofa duodenal orgastric ulcer in two different populations living in the same region: A cross-sectional endoscopical study inconsecutive patients, Neth J Med, 59, 209, 10.1016/S0300-2977(01)00161-9 Roosendaal, 1997, Helicobacter pylori and the birth cohort effect: Evidence of a continuous decrease of infection rates in childhood, Am J Gastroenterol, 92, 1480 Loffeld, 2003, H. pylori and reflux esophagitis in Turkish patients living in the Zaanstreek region in the Netherlands, Dig Dis Sci, 48, 1846, 10.1023/A:1025428019317